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In vitro metabolic zonation through 
oxygen gradient on a chip
federica tonon1, Giovanni Giuseppe Giobbe  2,3, Alessandro Zambon3, camilla Luni  4, 
onelia Gagliano3,6, Annarosa floreani5, Gabriele Grassi1 & nicola elvassore  2,3,4,6
Among the multiple metabolic signals involved in the establishment of the hepatic zonation, oxygen 
could play a key role. indeed, depending on hepatocyte position in the hepatic lobule, gene expression 
and metabolism are differently affected by the oxygen gradient present across the lobule. The aim of 
this study is to understand whether an oxygen gradient, generated in vitro in our developed device, is 
sufficient to instruct a functional metabolic zonation during the differentiation of human embryonic 
stem cells (hESCs) from endoderm toward terminally differentiated hepatocytes, thus mimicking the 
in vivo situation. For this purpose, a microfluidic device was designed for the generation of a stable 
oxygen gradient. The oxygen gradient was applied to differentiating hESCs at the pre-hepatoblast 
stage. The definitive endoderm and hepatic endoderm cells were characterized by the expression of 
the transcription factor SOX-17 and alpha-fetoprotein (AFP). Immature and mature hepatocytes were 
characterized by hepatocyte nuclear factor 4-alpha (HNF-4α) and albumin (ALB) expression and also 
analyzed for cytochrome P450 (CYP3A4) zonation and glycogen accumulation through PAS staining. 
Metabolic zonated genes expression was assessed through quantitative real time pcR. Application of 
the oxygen gradient during differentiation induced zonated glycogen storage, which was higher in the 
hepatocytes grown in high po2 compared to those grown in low po2. the mRnA levels of glutamine 
synthetase (GLUL), beta-catenin (CTNNB) and its direct target cyclin D1 (CCND1) showed significantly 
higher expression in the cells grown in low po2 compared to those grown in high po2. on the contrary, 
carbamoyl-phosphate synthetase 1 (CPS1), ALB, the proliferative marker ki67 (MKI67) and cyclin A 
(CCNA) resulted to be significantly higher expressed in cells cultured in high pO2 compared to those 
cultured in low po2. these results indicate that the oxygen gradient generated in our device can instruct 
the establishment of a functional metabolic zonation in differentiating hESCs. The possibility to 
obtain differentiated hepatocytes in vitro may allow in the future to deepen our knowledge about the 
physiology/pathology of hepatocytes in relation to the oxygen content.
Many human tissues exhibit spatial heterogeneity along the blood flow axis in terms of cell morphology, tran-
scriptomic/proteomic profile and the regulation of metabolic activities in both health and disease. This hetero-
geneity can be ascribed to the presence of different gradients, such as oxygen, cytokines, nutrients, and specific 
signaling events during the development, which promote a multifaceted pattern of tissue behaviors1.
The liver is probably the most representative organ where spatial heterogeneity takes place. The liver tis-
sue shows changes in functional and metabolic activities across the hepatic sinusoid, a phenomenon known as 
“zonation”, which occurs from the periportal to the perivenous region. Due to zonation, a different distribution 
through the liver lobule of nitrogen, carbohydrate, xenobiotic, other metabolites and protein synthesis occurs1. 
Particularly relevant for proper hepatocyte differentiation and specialization/maturation, as well as for the cre-
ation of the metabolic zonation, is the presence of an oxygen gradient. In vivo, hepatocytes are exposed to an 
oxygen gradient that influences gene expression, metabolism, and produces a considerable heterogeneity and 
functional plasticity in liver parenchyma2. Cells in the periportal zone of the hepatic lobule, receiving oxygen-rich 
blood (O2 partial pressure 60–70 mmHg) from the hepatic artery and nutrient-rich blood from portal vein, 
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catalyze predominantly oxidative energy metabolism using fatty acid β-oxidation and amino acid catabolism1,3. In 
contrast, the perivenous hepatocytes, being in the proximity to the central vein, receive poorly oxygenated blood 
(O2 partial pressure 25–35 mmHg) and activate mainly the metabolic pathways of glycolysis and liposynthesis1,3. 
Somehow peculiar is the metabolic pathway leading to the synthesis of glycogen. While in the perivenous zone, 
glycogen synthesis is activated when the starting substrate is glucose, in the periportal zone glycogen synthesis 
is promoted when the starting substrate is lactate2. In addition, the synthesis of certain plasma proteins, such 
as albumin, occurs mainly in the periportal area4. Recently, it has been suggested the master role of the Wnt/
beta-catenin pathway in the direct regulation of the gene expression pattern on which the metabolic zonation is 
probably based1,5. For example, Wnt/β-catenin pathway seems to regulate the expression of many genes involved 
in the urea cycle and glutamine synthesis, including CPS1 and GLUL. In particular, these two transcripts are 
upregulated and downregulated in the periportal and perivenous region, respectively4–6. Moreover, the prolif-
eration rate of the periportal hepatocytes results to be higher compared to that of the perivenous hepatocytes7.
The availability of in vitro cultured hepatocytes stably resembling the heterogeneity of phenotypes of liver 
hepatocytes in vivo, could be of great advantage to study the physiological and the pathological behaviors of the 
different population of hepatocytes. Given the driving role of oxygen gradient in the formation of the hepatic 
metabolic zonation8, the generation of devices able to reproduce the proper oxygen gradient is a prerequisite to 
mimic in vitro the in vivo condition. Moreover, because some events of liver zonation start already at the embry-
onic stage5, the use of differentiating hepatocytes in in vitro models may provide more physiological information 
than the use of differentiated hepatocytes.
In the last years, many tools and technologies have been proposed to create spatio-temporal gradients for cell 
studies9–12. Among these, microfluidic is certainly one of the most promising techniques due to its great control-
lability in both spatial and temporal domains8,9. Some devices were developed to establish an oxygen gradient in 
order to stimulate mature hepatocytes to get a zonation-like phenotype. Other systems allowed the generation 
of oxygen gradients on cultured primary rat hepatocytes and fibroblasts. In all these cases, cells were exposed to 
chemical gradient established by continuous perfusion, which, unfortunately, did not allow decoupling the con-
trol of medium delivery from the oxygen concentration. Moreover, these studies provided experimental evidences 
for primary animal cells, but not human hepatocytes13–15. In other approaches1,16, primary human hepatocytes 
were applied in oxygen-dependent modelling. However, a model of hepatic zonation and functional maturation 
starting from human pluripotent cells undergoing hepatic differentiation was never reported before.
In this work we studied the effects of an oxygen gradient, applied during differentiation from endoderm- 
committed cells to hepatocytes, on the establishment of a functional hepatic zonation. To this purpose, we devel-
oped a microfluidic cell culture device capable to generate a stable oxygen gradient, mimicking the one to which 
differentiated hepatocytes are physiologically exposed, independently from medium perfusion.
Our device can generate an oxygen gradient with long-term stability and full compatibility with biological 
incubator. The entire microfluidic device is made of glass and polydimethylsiloxane (PDMS), an elastomeric 
material that is biocompatible, optically clear and inert, and has great gas permeability17. O2 spatial concentration 
was probed by fluorescence of a ruthenium-based compound solution to characterize the oxygen gradient formed 
inside the chambers of the microfluidic device.
As cell model, we employed differentiating human embryonic stem cells. In addition to the oxygen gradient, 
hESCs were exposed to the conditions we previously showed to induce hepatic differentiation in a microfluidic 
environment18,19. Thus, we had the possibility to study the effects of the oxygen gradient on differentiating hepat-
ocytes. Our data indicate that the microfluidic cell culture device is suitable to generate a stable oxygen gradient. 
Moreover, the gradient positively affects the phenotype and gene expression of differentiating hepatocytes as it 
occurs in the different zones of the hepatic lobule.
Results
Description and testing of the microfluidic device. To mimic the physiologic condition existing in 
the liver lobule, we developed a microfluidic cell culture device where hepatocytes are differentiated from hESCs 
under an O2 gradient (Fig. 1A). The microfluidic device includes channel-shaped cell culture chambers whose 
geometry was previously used for hepatic differentiation from human pluripotent cells18. Along one side of the 
culture chamber, a 95% N2/5% CO2 gas mixture is continuously flowed; this region is separated from the culture 
channel by a thin gas-permeable membrane made of PDMS able to produce a localized decrease of oxygen con-
centration with respect to the incubator gas composition.
We first performed a computer-assisted design of the system to check the spatial control of the oxygen con-
centration. The computational model was used to simulate the feasibility of producing a stable oxygen gradient 
across the culture chamber along the whole length of it, and to determine the minimum suitable gas flow rate 
(Fig. 1B). Simulation results have been computed with an environmental gas composition of 21% oxygen, as in a 
standard normoxic biological incubator. Oxygen concentration goes from a high level to a low level correspond-
ently to the concentration into the gas channels. The simulated oxygen gradient ranges from 160 mmHg (21%) to 
15 mmHg (2%). Cell oxygen consumption was also taken into account in the simulation (Fig. 1C). Figure 1D,E 
show the setup design and an image of the final chip made of transparent PDMS, attached onto a glass slide. 
The chip includes three independent parallel culture chambers. Figure 1F shows the experimental validation 
of the system at steady state. A ruthenium solution was used in the channel as fluorescence sensor of oxygen 
concentration. The time required for achieving a stable oxygen gradient after starting the gas inflow is less than 
1 minute (Suppl. Vid. 1). Ruthenium emits higher green fluorescence at decreasing oxygen concentration. The 
oxygen profile shown in Fig. 1G was derived with Stern-Volmer equation and indicates that it is possible to obtain 
different zones in the culture chamber of approximately 1500 µm width: a low oxygen concentration close to the 
gas channel, an intermediate zone in the middle and a normal oxygen concentration at the opposite side of the 
channel. The O2 profile obtained experimentally is consistent with the simulation of the computational model.
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HESCs can be differentiated into microfluidic channels to obtain hepatocyte-like cells. By 
means of the microfluidic device developed, hESCs were differentiated into hepatocyte-like cells under a sta-
ble oxygen gradient using a 17-day differentiation protocol we previously described18. Cells were characterized 
for the expression of hepatic differentiation markers, at each stage of the microfluidic differentiation. The cell 
committed to definitive endoderm (DE) showed SOX-17 homogeneous expression (day 5 of differentiation). 
Hepatic endodermal (HE) cells showed high expression of alpha-fetoprotein (day 8). Immature hepatocytes (IH) 
showed homogenous expression of HNF-4α and alpha-fetoprotein (day 13). At day 17 of differentiation, mature 
hepatocyte-like cells (MH) showed polygonal cell shape, and high and homogeneous expression of ALB (Fig. 2A).
In order to understand whether different oxygen concentration could impair survival or differentiation 
capacity, we firstly performed separated high (21%) and low (5%) oxygen differentiation experiments. Cells ana-
lyzed at day 12 (IH) showed high viability and almost absent cell death in both high and low O2 concentrations 
(Fig. 2B). Furthermore, cells analyzed at day 13 (IH) showed high and homogeneous expression of HNF-4α and 
alpha-fetoprotein along the channels, in high as well as low O2 concentrations (Fig. 2C).
Figure 1. Microfluidic chip design and oxygen gradient validation. (A) Representative image of the liver 
zonation generated across the hepatic lobules. Hepatocytes are naturally exposed to an oxygen gradient 
according to their position along the portal-central axis that allows distinguishing “periportal” from 
“perivenous” hepatocytes. Schematic representation of miniaturization process of the sinusoid geometry 
transferred to microfluidic cultures. (B) Simulation results of the steady-state oxygen concentration in the 
vertical cross section of the PDMS chip. Color bar shows the normalized oxygen concentration (c’) between  
0 and 1. The section of cell culture and gas flow channels is also indicated. (C) Simulated steady-state profile of 
the scaled oxygen concentration at the bottom of the culture chamber as indicated in B, with or without cell.  
(D) Schematic section S1 (left) and top view (right) of the microfluidic gradient chip. Red: 95% N2/5% CO2 gas 
flow channels. Cyan: culture chambers. (E) Picture of the microfluidic chip filled with dyes according to the 
colors in D. (F) Fluorescent images of the culture chambers filled with an oxygen-sensitive ruthenium solution 
in PBS 1X, without gas inflowing into the gas channel (left in red) and at steady-state with nitrogen and carbon 
dioxide gas mixture flowing at 1 mL/min (right in blue). (G) Normalized fluorescent intensity along the culture 
channel cross-sections highlighted by red and blue lines in F. Red: control condition without gas flow. Blue: 
steady-state condition with gas flowing at 1 mL/min flow rate at the right side of the microchannel.
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the stable oxygen gradient in the microfluidic chambers induces metabolic zonation in 
hESCs-derived hepatocyte-like cells. In order to obtain a measurable effect on the differentiating cells, 
we applied an oxygen gradient, across the microchannels of the microfluidic device. We observed that the appli-
cation of the gradient from day 1 of differentiation causes impairment in early differentiation with differential 
alpha-fetoprotein expression across the channel at day 8 (Suppl. Fig. 1). To avoid any bias in late differentiation, 
we homogenously differentiated the cells without any gradient, at standard O2 (21%) up to the stage of hepatic 
endoderm (day 8), and then applied the O2 gradient until the mature hepatocyte stage (day 17), for a total of 9 
days.
We first proved that on the last differentiation day (day 17), mature hepatocytes were homogenously distrib-
uted in the microfluidic channels (Fig. 3A). By immunofluorescence analysis we studied the differential expres-
sion of the drug-metabolizing enzyme CYP3A4 across the microchannel width (Fig. 3B). CYP3A4 fluorescence 
was quantified in Regions Of Interest (ROI) localized in the upper (high O2), middle (intermediate O2), and 
lower (low O2) sections of the gradient channel width; in parallel a quantification of non-gradient channels dif-
ferentiated at ambient oxygen (high O2) was performed. Relative fluorescence unit plot shows a higher CYP3A4 
expression in lower oxygen concentration, with a constant decrease in expression as O2 increases in the gradi-
ent1,20 (Fig. 3C).
The physiologic and metabolic effects of the O2 gradient on differentiated hepatocyte-like cells were also ana-
lyzed by evaluating one of the main markers of zonation i.e. glycogen synthesis. Glycogen accumulation was 
quantified implementing an image analysis algorithm that classifies PAS positive or negative pixels according to 
the image saturation intensity. This algorithm was first trained by comparing pictures of PAS staining obtained 
from cells treated/untreated with diastase (Fig. 3D). Subsequently, the test was applied to differentiated hepato-
cyte like cells (Fig. 3E). In this case, higher glycogen storage at the side of the chambers in high pO2 compared to 
Figure 2. Characterization of hESCs (MShef-3 line) hepatic differentiation into a microfluidic chip.  
(A) Cells showing SOX-17 (green) at day 5, alpha-fetoprotein (green) at day 8, HNF-4α (red) and alpha-
fetoprotein (green) at day 13, albumin (red) and f-actin (green) at day 17 of differentiation. Scale bars 200 μm 
(microchannel) and 20 μm (inset). (B) Live/Dead assay showing high (left) and low (right) O2 differentiated 
hESCs at day 12 in microfluidic chips (3 parallel channels above, with enlargement below). Cell nuclei 
counterstained with Hoechst in blue, dead cells stained in red with ethidium homodimer-1, living cells 
fluorescence in green with calcein AM. Scale bars 300 μm (microchannels, above) and 10 μm (enlargement, 
below). (C) Day 13 differentiated hESCs showing HNF-4α (red) and alpha-fetoprotein (green), in high (above) 
and low (below) O2 differentiation experiments. Scale bars 100 μm (microchannel) and 50 μm (inset).
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low pO2 was observed. In contrast, no difference in glycogen storage was observed at the two sides of the control 
chip channels (not exposed to O2 gradient throughout differentiation, Fig. 3F). These findings suggest that in our 
gradient chips, glycogen synthesis mainly originates from lactate, as it occurs for hepatocytes exposed to high pO2 
in the periportal zone of the hepatic lobule2.
To further investigate whether the induction of a functional differentiated metabolic zonation in hepatic cells 
is effectively determined by an oxygen gradient, we analyzed the mRNA levels of two genes involved in the urea 
cycle, GLUL and CPS1, encoding for glutamine synthetase and carbamoyl-phosphate synthetase 1, respectively. 
Moreover, we evaluated the expression of beta-catenin and its substrate cyclin D1. Finally, we checked the level 
of proliferation by quantifying cell number and the markers cyclin A and MKI67. Microchannel monolayers of 
cells were carefully isolated longitudinally, and manually divided into two sections (high and low O2) for differ-
ential RNA analysis (Suppl. Vid. 2 and Suppl. Fig. 2). No significant changes were observed in hepatocyte-like 
cells differentiated at constant high pO2, between the two sides of the channel (control chip) (Fig. 4A). On the 
contrary, in the gradient chips, the mRNA levels of GLUL, beta-catenin (CTNNB) and its direct target cyclin D1 
(CCND1) showed significantly higher expression in the cells grown in low pO2 compared to those grown in high 
pO2 (Fig. 4B). Moreover, CPS1, albumin (ALB), MKI67 and cyclin A (CCNA) resulted to display significantly 
higher expression in cells cultured at high pO2 compared to those cultured in low pO2 (Fig. 4C).
Together, these observations indicate that the oxygen gradient generated by our device has a direct effect on 
the regulation of gene expression. Moreover, the observed regulation is consistent with the oxygen-dependent 
gene expression found in the different zones of the hepatic lobule4,21,22.
Figure 3. Liver zonation and hepatic glycogen storage evaluation. (A) Microfluidic differentiated (HES2 line) 
hepatocyte under constant oxygen gradient at day 17 of differentiation. Nuclear counterstain with Hoechst 
(blue) and f-actin staining (green). Scale bar 300 µm. (B) CYP3A4 (red) staining with representative images of 
day 17 differentiated hepatocytes across the gradient microchannel. Scale bar 20 µm. (C) Relative fluorescence 
unit plot of ROI in gradient microchannels and control microchannels (high O2 differentiation). Data are 
expressed as mean ± SD (n > 10) and trend line. (D) Example of automated recognition of Periodic Acid-Shiff 
(PAS+) areas in images taken after PAS staining of hepatocyte-like cells, without or with diastase (indicated 
with D) treatment. (E) Representative color images of PAS staining in hepatocyte-like cells grown in control and 
O2 gradient chip (with enlargement inset), respectively. Scale bar 100 µm. (F) Quantification of PAS+ areas in 
images obtained from the control and O2 gradient chip, shown in E. Data were acquired from the central part of 
the channel to the borders. Data are expressed as mean ± SD (n > 9). *Student’s t-test p < 0.05.
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The increased expressions of the proliferation markers MKI67 and cyclin A suggest an augmented growth 
rate of cells in high pO2. The increased expression of the G1-phase cycling D1, but not of the S-phase cyclin A 
in cells maintained in low pO2, suggest the incapacity of these cells to progress from the G1 to the S-phase of the 
cell cycle. To confirm the increased proliferation rate in high pO2, we performed cell counting on KI-67 immu-
nostained cells, which revealed a higher number of KI-67 positive cells in high pO2 compared to low pO2 (Suppl. 
Fig. 3A). This observation was also confirmed by cell nuclei counting which revealed 16% more nuclei in high 
pO2 compared to low pO2 (Suppl. Fig. 3B).
Discussion
In standard differentiation cultures23–25 it is still problematic to accurately reproduce the phenomenon occurring 
in vivo with regard to the differentiation of stem cells towards hepatocyte-like cells. Moreover, hepatic differen-
tiation from human pluripotent stem cells requires long-term experiments and up to 3 weeks could be needed 
for functional differentiation. Therefore, simple and easy to operate devices are desired from the biological com-
munity. The use of advanced technologies can minimize the above problems and better mimicking the in vivo 
differentiation process. Thus, advanced technologies have the potential to allow the generation of hepatocytes 
usable for drug screening, toxicological assays and may be also as liver disease in vitro models.
The O2 gradient has a fundamental impact on hepatocytes phenotype and functions across the liver lob-
ule4–6,26. Thus, in this work a microfluidic cell culture chip was designed and developed to create a stable oxygen 
gradient for several days that could be easily operated by simple manual maneuvers or coupled to automatic cell 
culture liquid handling.
The in vivo O2 gradient to which sinusoidal hepatocytes are exposed is 60–70 mmHg (8–9%) to 25–35 mmHg 
(3–4%)26. This range is too small for a first demonstration of gradient differentiation, thus, to give the proof of 
Figure 4. Gene expression analysis in hepatocyte-like cells (HES2 line). In all panels, the levels of the target 
mRNA are normalized to the expression level of the 28S rRNA. (A) Real-time PCR of genes involved in 
metabolic and cell cycle processes in hepatocyte-like cells obtained following hESCs differentiation at uniform 
21% O2 concentration (control chip). No statistical difference is observed between the right side and the left 
side. Data, normalized to the average of the right side, are shown as mean ± SEM. n = 3. Real-time PCR of genes 
involved in metabolic and cell cycle processes in hepatocyte-like cells grown in a stable O2 gradient generated 
by the microfluidic device. (B) GLUL (glutamine synthetase), CTNNB (beta-catenin) and CCND1 (cyclin 
D1) show significantly higher expression in low pO2. (C) CPS-1 (carbamoyl-phosphate synthetase 1), ALB 
(albumin), MKI67, CCNA (cyclin A) show significantly higher expression in high pO2. Data, normalized to the 
average of 21% O2, are shown as mean ± SEM. n = 9. p* < 0.001 and p§ < 0.0001 respect to 21% O2.
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concept and try to observe actual results on our cultures, we enlarged the O2 gradient range across the microchan-
nels, according to simulation results of the computational model.
Our experimental data indicate that this device is suitable to generate a stable oxygen gradient, and that the 
gradient affects cell phenotype and gene expression in a similar fashion to what occurs in the hepatic lobule, 
with differential expression of drug-metabolizing enzymes (CYP3A4). A major effect on glycogen metabolism 
is observed in the different hepatocytes derived from hESCs, according to their relative position in the oxy-
gen gradient. Glycogen storage changes according to the level of oxygen, recapitulating the specialization of the 
hepatocytes in an in vivo microenvironment. Moreover, transcripts that are differentially expressed across the 
liver sinusoid, such as GLUL, CPS1, CCND1, CCNA and ALB, are differentially expressed in the monolayer of 
cells across the microfluidic channels, according to their specific position/O2 concentration. We could not assess 
a functional differential localization for CTNNB protein (beta-catenin) across the microfluidic oxygen gradient, 
due to limitation in retrieving a sufficient quantity of cells from microchannels for proteomic analyses. Despite 
this, for the proliferation marker Ki67 we could show a direct correspondence between the mRNA (Fig. 4) and 
the protein level (Suppl. Fig. 3A).
conclusions
Together, our results show how an oxygen gradient alone can significantly promote the establishment of a func-
tional hepatic metabolic zonation during hESCs differentiation towards hepatocytes. These findings highlight 
oxygen as a relevant driving signal for the establishment of the zonation between the periportal and perivenous 
region in the hepatic sinusoid.
Despite this consideration, we cannot exclude that other factors can be involved in the induction of liver zona-
tion in our system. It is known that, in vivo, dynamic gradients of different modulators such as cytokines and/or 
signaling molecules contribute to the zonation effect1.
In this perspective, it is possible that cells undergoing zonation can produce and release in the extracellular 
environment factors promoting zonation in our system. The production of factor(s) that can influence in an auto-
crine fashion the neighboring cells has not been investigated here. However, our model has the potential to allow 
investigation also in this sense.
In conclusion, the device developed can physiologically induce the differentiation of hepatocytes which, in 
the future, may be used to deepen our knowledge about the physiology/pathology of periportal and perivenous 
hepatocytes and possibly to reconstitute the diseased liver tissue.
Materials and Methods
Microfluidic device design and fabrication. Microfluidic device (referred as ‘chip’) designed to 
run experiments in triplicate, is composed of culture chambers and gas channels. Each culture chamber 
(18 × 1.5 × 0.25 mm) is separated for the entire length by a 100 µm membrane from a gas channel on both the 
sides. The gas channel (250 µm wide and 250 µm high) has one entrance that divides in two parallel channels 
in order to distribute the gas mixture equally for the three culture channels. The chip has been fabricated with 
standard photo-lithography techniques27 using SU8 2100 (Microchem). The chip has been replicated using PDMS 
(Sylgard 184, Dow Corning) in the rate 10:1 base:cure agent. Holes in the channels have been created using a 21G 
dispensing needle (Small Part Inc). The chip has been bonded via plasma treatment (Harrick Plasma, 120 s) on a 
soda lime glass slide (Menzel Glaser). A PDMS medium reservoir of about 200 µL has also been plasma-bonded 
to the designated outlet side. We also covered the upper surface of the chip with 100 µm coverslip glass slide in 
order to reduce water permeation and increase gradient efficiency.
computational model. For computer-assisted microfluidic chip design, we implemented a computational 
model to simulate the effect of gas stream concentration into the channel during steady state. The mathematical 
model was implemented and solved using Comsol Multiphysics (version 4.4 CLK) by diffusion with flux, insula-
tion and concentration boundary condition. We simulated a chip section composed of culture chamber and gas 
mixture chambers supposing to place the chip in normoxic environment modifying the boundary condition in 
terms of concentration. Since PDMS has high gas permeable diffusion, a stable oxygen concentration can be gen-
erated by oxygen diffusion through a membrane that separates gas and flow chambers. We also studied the effect 
of insulation of the top of the chip on the concentration gradient distribution. For the simulation, we assumed 
that at higher gas flow rate (>0.1 mL/min) oxygen concentration in the center and in the wall of the gas channel 
was constantly maintained for the entire length of the channels and equal to the inlet concentration. The oxygen 
diffusion parameters [m2/s] used in the simulation are: in PDMS 4.10−09, in PBS 2.10−09 and in Air 2.00−05.
Generation and characterization of the oxygen gradient. Every microfluidic channel is enclosed 
between a pre-humidified gas stream without oxygen (O2 0%, N2 95%, CO2 5%) simulating the hypoxic condition, 
and the atmospheric oxygen in the incubator (O2 21%), which acts as an infinite atmospheric oxygen reservoir. 
The hypoxic mixture is generated via mass flow meters (Bronkhorst) controlled through software FlowDDE32. 
The gas mixture constant flow is 1 mL/min. Before entering in the gas channels, the mixture is humidified and 
warmed by gurgling through a tank filled with distilled water placed at 37 °C. All the fluidic and gas connec-
tions were made with PTFE tubes (Cole Parmer). The gradient generation and stability were validated using 
a 100-mM solution of tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) dichloride complex (Ru(ddp) – 
Sigma-Aldrich). Fluorescence of Ru(ddp) was detected by an inverted fluorescent microscope Leica DMI600B 
equipped with a mercury short-arc reflector lamp (Leica) excited at BP 450–490 nm and acquisition at LP 590. 
The Ru(ddp) solution was loaded inside the culture channels using a syringe pump (Harvard Apparatus) using 
3-ml syringes (BD Plastic) at a flow rate of 500 nL/min. Images were taken every 5 sec at constant flow rate 
8Scientific RepoRtS |         (2019) 9:13557  | https://doi.org/10.1038/s41598-019-49412-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
under steady state conditions to avoid Ru(ddp) bleaching. To correlate the fluorescence intensity, we applied the 
Stern-Volmer equation28:
τ= +
I
I
k O1 [ ]q0 0 2
where I0 and I  are the fluorescence intensities of Ru(ddp) probe in the absence and presence of oxygen, kq is the 
quencher rate coefficient (in m3/mol/s, derived from the Stokes-Einstein relation), τ0 is the unquenched 
excited-state lifetime (previously reported to be ~ ⋅ −6 10 6 s29, and O[ ]2  is the concentration of oxygen in solution 
in mol/m3, obtained from Henry’s law with a Henry’s constant in water at 37 °C of 5.1848 ∙ 109 Pa30.
Cell culture and differentiation protocol. The human embryonic stem cells used for the experiments 
are HES2 line obtained by the National Stem Cell Bank (Madison, WI) and MShef-3 obtained by UCL (London).
HES2 were cultured on gelatin-coated multiwells with mitomycin C-treated mouse embryonic fibroblasts 
(Chemicon) co-culture, in expansion medium DMEM F-12 supplemented with 20% KO serum, 10% MEF con-
ditioned medium, 20 ng/mL basic fibroblast growth factor, 0.1 mM β-mercaptoethanol, 1% non-essential amino 
acid (NEAA) and 1% penicillin-streptomycin (Thermo Fisher). HES2 were passaged to new feeder with trypsin 
0.25% (Thermo Fisher). For MEFs depletion and cell differentiation, cells were passaged on matrigel reduced fac-
tor (BD Bioscience) coated channels of microfluidic device. MShef-3 cells were expanded feeder-free in mTeSR™1 
Medium (Stemcell Tech) defined medium, on 0.5% matrigel coated plates. Cell suspensions were injected into 
channels and incubated overnight at 37 °C and 5% CO2 atmosphere without perfusion, to allow cell adhesion to 
substrate.
Cell differentiation started when cells reached a confluence level of approximately 70% by replacing stem cell 
expansion medium with endoderm induction medium for 3 days, containing RPMI 1640, 1X B27 supplement 
(both Thermo Fisher), 100 ng/mL human activin A (Peprotech), 50 ng/mL human wnt-3a (R&D Systems) and 
1% penicillin-streptomycin. Medium was changed to differentiation medium, KO-DMEM with 20% KO serum, 
1% NEAA, 1 mM glutamine, 0.1 mM β-mercaptoethanol, 1% penicillin-streptomycin (all Thermo Fisher) and 
1% DMSO (Sigma-Aldrich) for 5 days. At this stage of differentiation (day 8), oxygen gradient is applied to cul-
ture system. Cells were subsequently cultured for other 9 (or more) days in maturation medium containing L15 
medium (Sigma-Aldrich), 8.3% FBS (Thermo Fisher), 8.3% tryptose phosphate broth, 10 µM hydrocortisone
-21-hemisuccinate, 1 µM insulin (all Sigma-Aldrich), and 2 mM glutamine with 10 ng/ml human hepatocyte 
growth factor and 20 ng/ml human oncostatin-M (both R&D Systems). The medium in the microchannel was 
changed every 12 h during differentiation18.
RNA extraction and qRT-PCR. For cell extraction, PDMS upper parts of the microfluidic chips were 
peeled off from the glass slides with adherent cells. Channels monolayers were manually divided and picked with 
a glass pipette on the stereomicroscope to separate the cells growing in the low O2 side of the channel from the 
high O2 side.
Total RNA was then extracted from the collected hepatocyte-like cells by using 0.5 ml of Trizol Reagent 
(Thermo Fisher) per sample or pooled samples. Chloroform (Sigma-Aldrich) 0.1 mL was added to Trizol for 
3 min and centrifuged at 12500 g for 15 min at 4 °C. Aqueous supernatant was collected and diluted 1:1 with 70% 
ethanol. Total RNA was extracted from solution using RNeasy Mini Kit (Qiagen), following the manufacturer’s 
instructions. The Nanodrop ND 1000 (Cell Euroclone) is used to determinate RNA concentration and quality. 
500 ng of total RNA was reverse transcribed using MMLV reverse transcriptase (Thermo Fisher). The following 
primers are used for quantitative real time PCR (qRT-PCR):
β-Catenin, FW 5′-GCT TTC AGT TGA GCT5 GAC CA-3′, REV 5′-CAA GTC CAA GAT CAG CAG TCT-3;
Cyclin D1, FW 5′-CCG TCC ATG CGG AAG ATC-3′; REV 5′-CCT CCT CCT CGC ACT TCT GT-3′;
Cyclin A, FW 5′-GTC AGA GAG GGG ATG GCA T-3′, REV 5′-CCA GTC CAC CAG AAT CGT G-3′;
Albumin, FW 5′-CCT GTT GCC AAA GCT CGA TG-3′, REV 5′-GAA ATC TCT GGC TCA GGC GA-3′;
CPS1, FW 5′-GGC CAT CCA TCC TCT GTT GC-3′, REV 5′-GCT AAG TCC CAG TTC ATC CA-3′;
GLUL, FW 5′-GCC ATG GGG GAG GAG AAT-3′, REV 5′-ACT GGT GCC GCT TGC TTA GT-3′;
MKI67, FW 5′-GCC TGC TCG ACC CTA CAG A-3′, REV 5’– GCT TGT CAA CTG CGG TTG C-3′;
28S, FW 5′-TGG GAA TGC AGC CCA AAG-3′, REV 5′-CCT TAC GGT ACT TGT TGA CTA TGC-3′.
For the qRT-PCR the amplification steps were the following: pre-denaturation at 95 °C for 10 min, 40 cycles of 
amplification with denaturation at 95 °C for 15 s, annealing at proper temperature for 60 s and extension at 72 °C 
for 30 s. An extension step at 72 °C for 10 min and a dissociation stage (95/60/95 °C for 15 s each) is finally added. 
The levels of target mRNAs have been normalized to the levels of the 28S rRNA.
Immunofluorescence assay. Immunofluorescence on endoderm and hepatocyte-like cells was performed 
after fixing cells with 4% PFA for 15 min. Definitive endoderm was marked with antibody SOX-17 1:100 (AF1924, 
R&D) incubated in 5% horse serum (Thermo Fisher), PBS/Triton X-100 0.3% for 1 h at room temperature (RT). 
Hepatic endoderm was marked with α-fetoprotein 1:250 (A8452, Sigma-Aldrich). Immature hepatocytes were 
stained with HNF-4α 1:50 (sc-8987, Santa Cruz Biotechnology). Mature hepatocyte-like cells were stained with 
albumin 1:100 (MAB1455, R&D), and CYP3A4 (GTX60577, Genetex) incubated in 10% FBS, PBS/Triton X-100 
0.1% overnight at 4 °C. For secondary antibody and staining we used Alexa Fluor 594 or 488, phalloidin-488, 
Hoechst (all Thermo Fisher) for 1 h at 37 °C.
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Cell viability assay (Live/Dead kit, Thermo Fisher) was performed on microfluidic differentiated cells. Cells 
were washed with basal DMEM-F12, incubated with 3 μM ethidium homodimer-1 (stains dead cells in red), 3 μM 
calcein AM (stains live cells in green) and 4 μM Hoechst (stains cell nuclei in blue) for 45 min at 37 °C, washed 
with DMEM-F12 and analyzed at fluorescence microscope.
Fluorescence quantification. Channel width was virtually divided in 3 sections (upper, middle, lower), 
and fluorescent pictures were acquired at the Leica DMI6000 B microscope (see Suppl. Fig. 1). From each photo, 
two regions of interest (ROI) were considered, for a total of 6 ROI for each microchannel section. ROI fluores-
cence was quantified using LasAf Lite software image analyzer, and relative fluorescent unit (R.F.U.) were plotted 
against ROI position across channel width.
Periodic acid schiff (PAS) stain and quantitative assay. To assess glycogen storage in hepatocyte-like 
cells, we performed the Periodic Acid Schiff (PAS) staining using Periodic Acid Schiff kit (Sigma-Aldrich) accord-
ing to manufacturer’s instructions. Briefly, hepatocyte-like cells were fixed in 4% PFA in PBS 1X for 15 min at RT, 
washed with PBS 1X (negative controls were treated with diastase 1 mg/mL for 15 min) and stained with periodic 
acid for 5 min at RT. After that, cells were washed with distilled water, stained with Schiff ’s reagent for 15 min at 
RT and then washed again with distilled water. Finally, cells were thoroughly washed with distilled water prior to 
microscopic examination.
To quantify the glycogen storage in terms of PAS+ area, microscopic images were first converted from RGB 
to HSV color space, and then only the saturation component was used for further processing. Saturation was 
thresholded according to a parameter that distinguishes between PAS+ and PAS− pixels. This parameter was 
manually chosen by comparing the saturation levels of PAS and diastase-treated PAS pictures and kept constant 
in the analysis of all the images.
Statistical analysis. Data are presented as mean ± SE or ± SD. T-test was held out by Instat 2.0 and 
Graphpad 6.1 software to determine the statistical differences between the analyzed groups. The degree of signif-
icance has been set at (p < 0.05).
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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